Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (661-670 of 942) with videos related to

Pageof 95
Sort By:
Journal of the American Heart Association|December 10, 2021
N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized CohortChristian O'Donnell, Melanie D Ashland, Elena C Vasti, et al.
The American Journal of Cardiology|October 29, 2005
Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)Shuaib M Abdullah, Amit Khera, Sandeep R Das, et al.
JAMA|December 15, 2005
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery diseaseDavid A Morrow, James A de Lemos, Michael A Blazing, et al.
Journal of the American Heart Association|July 20, 2016
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50Stephen K Kidd, Marc P Bonaca, Eugene Braunwald, et al.
JAMA|December 9, 2010
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general populationJames A de Lemos, Mark H Drazner, Torbjorn Omland, et al.
Pediatrics|June 1, 2016
Improving Care for Neonatal Abstinence SyndromeStephen W Patrick, Robert E Schumacher, Jeffrey D Horbar, et al.
The American Journal of Cardiology|November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarctionDimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
Circulation|September 7, 2007
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trialBenjamin M Scirica, David A Morrow, Hanoch Hod, et al.
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Critical Pathways in Cardiology|January 14, 2026
Considerations for the Adoption of Digital Algorithms and Cardiovascular Decision-Support Tools in Clinical PracticeChristopher W Baugh, C Michael Gibson, Evangelos Giannitsis, et al.
Pageof 95

Showing results (661-670 of 942) with videos related to

Sort By:
Pageof 95
Journal of the American Heart Association|December 10, 2021
N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized CohortChristian O'Donnell, Melanie D Ashland, Elena C Vasti, et al.
The American Journal of Cardiology|October 29, 2005
Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)Shuaib M Abdullah, Amit Khera, Sandeep R Das, et al.
JAMA|December 15, 2005
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery diseaseDavid A Morrow, James A de Lemos, Michael A Blazing, et al.
Journal of the American Heart Association|July 20, 2016
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50Stephen K Kidd, Marc P Bonaca, Eugene Braunwald, et al.
JAMA|December 9, 2010
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general populationJames A de Lemos, Mark H Drazner, Torbjorn Omland, et al.
Pediatrics|June 1, 2016
Improving Care for Neonatal Abstinence SyndromeStephen W Patrick, Robert E Schumacher, Jeffrey D Horbar, et al.
The American Journal of Cardiology|November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarctionDimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
Circulation|September 7, 2007
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trialBenjamin M Scirica, David A Morrow, Hanoch Hod, et al.
Clinical Chemistry|April 17, 2019
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Critical Pathways in Cardiology|January 14, 2026
Considerations for the Adoption of Digital Algorithms and Cardiovascular Decision-Support Tools in Clinical PracticeChristopher W Baugh, C Michael Gibson, Evangelos Giannitsis, et al.
Pageof 95